Makati Medical Center | Clinical Research Center

Research site

(Unclaimed)

Location

2 Amorsolo Street, Legaspi Village, Makati City, National Capital Region, Philippines

Site insights

Top conditions

Top treatments

Bevacizumab

Tocilizumab

Ritonavir

Avibactam

Thymidine

Fesoterodine

Olanzapine

MTZ

Paclitaxel

Atezolizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 30 total trials

A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)

This Phase III study is a global multicenter, randomized, double-blind,placebo controlled clinical trial to evaluate the efficacy, safety, and immuno...

Active, not recruiting

COVID-19

Other: Placebo control

Biological: Recombinant COVID-19 vaccine (Sf9 cells)

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease (CULTIVATE)

This is a Phase 2/3 study that comprises 5 substudies designed to evaluate the efficacy, safety, and tolerability of oral etrasimod as therapy in adu...

Enrolling

Crohn's Disease

Drug: Placebo

Drug: Etrasimod

A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab (IMbrave251)

This is a Phase III, open-label, multicenter, randomized, two-arm study designed to evaluate the efficacy and safety of atezolizumab plus either lenv...

Active, not recruiting

Unresectable Hepatocellular Carcinoma

Drug: Lenvatinib

Drug: Atezolizumab

A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH) (TOMORROW)

This is a prospective, multicenter, open-label, randomized, controlled, parallel Phase 3 study with an open-label single-arm extension period to eval...

Active, not recruiting

Pulmonary Arterial Hypertension

Drug: Macitentan

Other: Standard-of-care

GEN2 Directed Cancer Immunotherapy Trial

Phase 1, non-randomized, open label dose escalation clinical trial evaluating the safety of GEN2 in participants with primary \& metastatic liver tum...

Active, not recruiting

Metastatic Cancer

Hepatocellular Carcinoma

Drug: GEN2 (HSV-Thymidine Kinase-m2 and hGM-CSF Genes)

GEN3014 Safety Trial in Relapsed or Refractory Hematologic Malignancies

The drug that will be investigated in the study is an antibody, GEN3014. Since this is the first study of GEN3014 in humans, the main purpose is to e...

Enrolling

Acute Myeloid Leukemia (AML)

Relapsed or Refractory Multiple Myeloma (RRMM)

Biological: GEN3014

Drug: Daratumumab

Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer (POD1UM-304)

The purpose of this study is to assess the efficacy and safety of platinum-based chemotherapy with or without INCMGA00012 in participants with metast...

Active, not recruiting

Metastatic Nonsquamous Non-Small Cell Lung Cancer

Metastatic Squamous Non-Small Cell Lung Cancer

Drug: Placebo

Drug: Paclitaxel

Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase III (COVID-19)

A Global, Multi-center, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Study to Evaluate the Efficacy, Safety, and Immunogenicity o...

Active, not recruiting

COVID-19 Pandemic

Biological: Recombinant SARS-CoV-2 fusion protein vaccine (V-01)

Other: Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)